EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Canine Mammary Cancer: State of the Art and Future Perspectives

Eliza Vazquez, Yulia Lipovka, Alejandro Cervantes-Arias, Adriana Garibay-Escobar iD, Michelle M Haby iD, Felisbina Luisa Queiroga iD, Carlos Velazquez

Animals · 09.10.2023 · 13 (19) · 3147

DOI: 10.3390/ani13193147 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Animals, online erschienen am 09.10.2023. Verfasst von Eliza Vazquez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry-Biology, University of Sonora, Blvd. Luis Encinas y Rosales s/n, Hermosillo 83000, Mexico. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Portuguese Foundation for Science and Technology (FCT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mammary cancer is the most frequently diagnosed neoplasia in women and non-spayed female dogs and is one of the leading causes of death in both species. Canines develop spontaneous mammary tumors that share a significant number of biological, clinical, pathological and molecular characteristics with human breast cancers. This review provides a detailed description of the histological, molecular and clinical aspects of mammary cancer in canines; it discusses risk factors and currently available diagnostic and treatment options, as well as remaining challenges and unanswered questions. The incidence of mammary tumors is highly variable and is impacted by biological, pathological, cultural and socioeconomic factors, including hormonal status, breed, advanced age, obesity and diet. Diagnosis is mainly based on histopathology, although several efforts have been made to establish a molecular classification of canine mammary tumors to widen the spectrum of treatment options, which today rely heavily on surgical removal of tumors. Lastly, standardization of clinical study protocols, development of canine-specific biological tools, establishment of adequate dog-specific disease biomarkers and identification of targets for the development of new therapies that could improve survival and have less adverse effects than chemotherapy are among the remaining challenges.

Schlagwörter

Stichwörter der Autor:innen

caninediagnosismammary cancermolecular classificationtreatment

Autor:innen und Institutionen

  • Department of Chemistry-Biology, University of Sonora, Blvd. Luis Encinas y Rosales s/n, Hermosillo 83000, Mexico.
  • Department of Small Animal Medicine and Surgery, Small Animal Teaching Hospital, The National University of Mexico (UNAM), Ciudad Universitaria, Investigación Científica 3000, Coyoacán, Mexico City 04360, Mexico.
  • CECAV-Animal and Veterinary Research Center, University of Trás-os-Montes and Alto Douro, 5001-801 Vila Real, Portugal.

ORCID-Profile: Adriana Garibay-Escobar, Michelle M Haby, Felisbina Luisa Queiroga

Förderung

  • Fundação para a Ciência e Tecnologia
  • Portuguese Foundation for Science and Technology (FCT)

Zitieren

APA

Vazquez, E., Lipovka, Y., Cervantes-Arias, A., Garibay-Escobar, A., Haby, M. M., Queiroga, F. L., & Velazquez, C. (2023). Canine Mammary Cancer: State of the Art and Future Perspectives. Animals, 13(19), 3147. https://doi.org/10.3390/ani13193147

Vancouver

Vazquez E, Lipovka Y, Cervantes-Arias A, Garibay-Escobar A, Haby MM, Queiroga FL, et al. Canine Mammary Cancer: State of the Art and Future Perspectives. Animals. 2023;13(19):3147. doi:10.3390/ani13193147

BibTeX
@article{Vazquez2023,
  author = {Vazquez, Eliza and Lipovka, Yulia and Cervantes-Arias, Alejandro and Garibay-Escobar, Adriana and Haby, Michelle M and Queiroga, Felisbina Luisa and Velazquez, Carlos},
  title = {Canine Mammary Cancer: State of the Art and Future Perspectives},
  journal = {Animals},
  year = {2023},
  volume = {13},
  number = {19},
  pages = {3147},
  doi = {10.3390/ani13193147}
}
Kostenlos starten →